Phase 4 HIV and AIDS Trial, Recruiting (NCT05547048)

Phase 4 HIV and AIDS Trial, Recruiting NCT05547048 Sponsor: Yale University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT05547048 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are women
People who have access to a working mobile or landline phone
People who have been involved with the criminal justice system at some point in their life, such as being on probation, parole, supervised release, or having been released from a prison or jail
People whose HIV test (a same-visit blood test) comes back negative for HIV
People who meet the medical guidelines for taking a medication to help prevent HIV infection (confirm with trial site)
People who have an opioid use disorder, whether or not they are currently receiving treatment for it

Who may not be able to join:

People who are unable or unwilling to give their formal agreement to participate in the study
People who are currently pregnant or breastfeeding
People who are already taking HIV prevention medication (PrEP) at the time they would be enrolling in the study
People who are not comfortable having conversations in either English or Spanish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Carolina Price, MPA, Yale University

Phone: (203) 737-3393

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05547048

Sponsor: Yale University

Phase: Phase 4

Status: Recruiting

Condition: HIV and AIDS

Trial contact: (203) 737-3393

More information: https://clinicaltrials.gov/study/NCT05547048

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are women
People who have access to a working mobile or landline phone
People who have been involved with the criminal justice system at some point in their life, such as being on probation, parole, supervised release, or having been released from a prison or jail
People whose HIV test (a same-visit blood test) comes back negative for HIV
People who meet the medical guidelines for taking a medication to help prevent HIV infection (confirm with trial site)
People who have an opioid use disorder, whether or not they are currently receiving treatment for it

Who may not be able to join:

People who are unable or unwilling to give their formal agreement to participate in the study
People who are currently pregnant or breastfeeding
People who are already taking HIV prevention medication (PrEP) at the time they would be enrolling in the study
People who are not comfortable having conversations in either English or Spanish

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Yale University

Registry

ClinicalTrials.gov

Start date

25 July 2023

Est. completion

1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants who initiate PrEP

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov